a pharmacoeconomic analysis of multiple myeloma treatment
Published 6 years ago • 67 plays • Length 3:17Download video MP4
Download video MP3
Similar videos
-
1:53
the future of multiple myeloma treatment
-
0:59
defining the origins of multiple myeloma
-
1:54
the future of multiple myeloma treatment
-
2:37
meta-analysis of studies on biomarker-defined early multiple myeloma
-
1:08
novel immunotherapies for multiple myeloma & other exciting developments
-
3:06
the role of artificial intelligence for precision medicine in multiple myeloma
-
9:25
mgus diagnosis: a step-by-step approach
-
5:59
what is hrmm (high-risk multiple myeloma)?
-
1:03
advantages and applications of mass spectrometry in multiple myeloma
-
2:50
phase i study of abbv383, a novel bcmaxcd3 bispecific antibody, in r/r multiple myeloma
-
2:46
managing patients with high-risk myeloma
-
0:58
minimumm-seq: a novel, minimally invasive approach to characterize myeloma pathology
-
2:53
novel targets and dual-targeting approaches in myeloma
-
2:44
myeloma qol through induction and maintenance
-
1:28
evaluating next-generation immunotherapies in earlier lines of treatment in multiple myeloma
-
4:01
kenneth anderson: what are the next steps to a myeloma cure?
-
1:01
car-t: myeloma toxicities
-
0:52
novel strategies to evaluate biomarkers of interest in multiple myeloma
-
1:22
an all-molecular diagnostic approach for myeloma
-
2:36
a multi-omic study to improve the diagnosis of multiple myeloma
-
1:26
emerging monoclonal antibodies for the treatment of multiple myeloma
-
1:41
innovative treatment strategies for multiple myeloma